Furthermore, RNA decay assays demonstrated that IGF2BP3 inhibited MALAT1 decay rates, suggesting that IGF2BP3 stabilizes MALAT1 in HBV/HBx-expressing HCC cells (Fig. 4P). This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.